Derangère, V., Fumet, J. D., Boidot, R., Bengrine, L., Limagne, E., Chevriaux, A., . . . Ghiringhelli, F. (2016). Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer? Oncotarget.
Citação norma ChicagoDerangère, Valentin, et al. "Does Bevacizumab Impact Anti-EGFR Therapy Efficacy in Metastatic Colorectal Cancer?" Oncotarget 2016.
MLA citiranjeDerangère, Valentin, et al. "Does Bevacizumab Impact Anti-EGFR Therapy Efficacy in Metastatic Colorectal Cancer?" Oncotarget 2016.
Opozorilo: Ti citati niso vedno 100% točni.